170 related articles for article (PubMed ID: 35530138)
1. Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors.
Zhou Y; Tong F; Gu W; He S; Yang X; Li J; Gao YD; Gao H
Acta Pharm Sin B; 2022 Mar; 12(3):1416-1431. PubMed ID: 35530138
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
3. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
5. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
6. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
7. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
8. 3-Bromopyruvate-Conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor.
Deng Y; Song P; Chen X; Huang Y; Hong L; Jin Q; Ji J
ACS Nano; 2020 Aug; 14(8):9711-9727. PubMed ID: 32806075
[TBL] [Abstract][Full Text] [Related]
9. Oxygen-Self-Supplying and HIF-1α-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy.
Liu P; Xie X; Shi X; Peng Y; Ding J; Zhou W
ACS Appl Mater Interfaces; 2019 Dec; 11(51):48261-48270. PubMed ID: 31763809
[TBL] [Abstract][Full Text] [Related]
10. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
11. Application of tumor pH/hypoxia-responsive nanoparticles for combined photodynamic therapy and hypoxia-activated chemotherapy.
Zhang Z; Feng J; Zhang T; Gao A; Sun C
Front Bioeng Biotechnol; 2023; 11():1197404. PubMed ID: 37362218
[No Abstract] [Full Text] [Related]
12. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
[TBL] [Abstract][Full Text] [Related]
13. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Micelles Dually Responsive to Hypoxia and Singlet Oxygen: Enhanced Photodynamic Therapy via Interactively Triggered Photosensitizer Delivery.
Li J; Meng X; Deng J; Lu D; Zhang X; Chen Y; Zhu J; Fan A; Ding D; Kong D; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2018 May; 10(20):17117-17128. PubMed ID: 29722261
[TBL] [Abstract][Full Text] [Related]
16. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
[TBL] [Abstract][Full Text] [Related]
18. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
[TBL] [Abstract][Full Text] [Related]
19. Self-Rectifiable and Hypoxia-Assisted Chemo-Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.
Wang Y; Huo J; Li S; Huang R; Fan D; Cheng H; Wan B; Du Y; He H; Zhang G
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10092-10101. PubMed ID: 35170301
[TBL] [Abstract][Full Text] [Related]
20. Light-Induced Hypoxia-Triggered Living Nanocarriers for Synergistic Cancer Therapy.
Wang W; Lin L; Ma X; Wang B; Liu S; Yan X; Li S; Tian H; Yu X
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19398-19407. PubMed ID: 29781276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
